Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Operating Leases (2022 - 2025)

Biofrontera has reported Operating Leases over the past 4 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 349.28% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, up 349.28%, while the annual FY2025 figure was $1.2 million, 349.28% up from the prior year.
  • Operating Leases for Q4 2025 was $1.2 million at Biofrontera, up from $136000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $1.2 million in Q4 2025 and troughed at $136000.0 in Q3 2025.
  • A 4-year average of $535166.7 and a median of $502500.0 in 2023 define the central range for Operating Leases.
  • Biggest five-year swings in Operating Leases: crashed 65.67% in 2024 and later soared 349.28% in 2025.
  • Year by year, Operating Leases stood at $848000.0 in 2022, then fell by 5.19% to $804000.0 in 2023, then crashed by 65.67% to $276000.0 in 2024, then surged by 349.28% to $1.2 million in 2025.
  • Business Quant data shows Operating Leases for BFRI at $1.2 million in Q4 2025, $136000.0 in Q3 2025, and $223000.0 in Q2 2025.